Niagen Bioscience Says It Expects Full-Year Ingredient Business Below Prior Year As Commercial Partners Face More Competitive Market; Sees Niagen Plus And New Skincare Partnerships Contributing Beginning 2027

Benzinga Newsdesk www.benzinga.com Neutral 93.0%

Neg 0% Neu 93% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001386570/000138657026000043/cdcx-20260630.htm

Comments

No comments yet. Be the first!